Intended for healthcare professionals

News News Analysis

UK must focus on diagnostics needed to cut antimicrobial resistance, says review chair

BMJ 2022; 377 doi: (Published 23 June 2022) Cite this as: BMJ 2022;377:o1551
  1. Jacqui Wise
  1. Kent, UK

A major review in 2016 concluded that antimicrobial resistance, if left unchecked, could account for 10 million global deaths a year by 2050. Jacqui Wise reports from a parliamentary session discussing how well the UK is mitigating the risk of another pandemic

Politicians have failed to grasp the importance of new diagnostics to cut unnecessary use of antibiotics, the chair of a government commissioned review on antimicrobial resistance (AMR) has told MPs.

It is six years since economist Jim O’Neill published his review on antimicrobial resistance, which made 10 key recommendations, including promoting rapid point-of-care diagnostics in primary and secondary care.12

Giving evidence to the Commons Science and Technology Committee on 22 June, O’Neill said he was pleased that there had been progress on many of the report’s recommendations, particularly reducing unnecessary use of antimicrobials in agriculture.

“Woeful” progress on diagnostics

But he said there was one area where the UK has been “woeful.” …

View Full Text

Log in

Log in through your institution


* For online subscription